KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

West Pharmaceutical Services (WST) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for West Pharmaceutical Services (WST) over the last 17 years, with Q4 2025 value amounting to 0.17%.

  • West Pharmaceutical Services' Return on Capital Employed fell 200.0% to 0.17% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.17%, marking a year-over-year decrease of 200.0%. This contributed to the annual value of 0.18% for FY2025, which is 0.0% changed from last year.
  • As of Q4 2025, West Pharmaceutical Services' Return on Capital Employed stood at 0.17%, which was down 200.0% from 0.17% recorded in Q3 2025.
  • West Pharmaceutical Services' Return on Capital Employed's 5-year high stood at 0.29% during Q4 2021, with a 5-year trough of 0.17% in Q4 2025.
  • In the last 5 years, West Pharmaceutical Services' Return on Capital Employed had a median value of 0.21% in 2021 and averaged 0.22%.
  • In the last 5 years, West Pharmaceutical Services' Return on Capital Employed skyrocketed by 1000bps in 2021 and then tumbled by -800bps in 2023.
  • Over the past 5 years, West Pharmaceutical Services' Return on Capital Employed (Quarter) stood at 0.29% in 2021, then decreased by -13bps to 0.25% in 2022, then fell by -13bps to 0.22% in 2023, then fell by -15bps to 0.18% in 2024, then fell by -10bps to 0.17% in 2025.
  • Its Return on Capital Employed was 0.17% in Q4 2025, compared to 0.17% in Q3 2025 and 0.18% in Q2 2025.